Literature DB >> 24700645

Self-reported cognitive concerns and abilities: two sides of one coin?

Jin-Shei Lai1, Lynne I Wagner, Paul B Jacobsen, David Cella.   

Abstract

OBJECTIVE: Patient-reported cognitive function can be measured using negatively worded items (concerns) and positively worded (abilities) items. It is possible that reporting abilities is less subject to the influence of emotional states. This study evaluated the relationship between cognitive concerns and cognitive abilities.
METHODS: Cancer patients (N = 509; mean age = 61 years; 50% men; 86% White) completed concerns and abilities items developed by the National Institutes of Health Patient-Reported Outcomes Information System (PROMIS). Confirmatory factor analysis was used to evaluate the extent to which items were loaded on one single factor (unidimensionality). Multidimensionality was evaluated using bi-factor analysis (local factors: concerns and abilities). Slope parameters from multidimensional item response theory (IRT) and unidimensional IRT were compared to evaluate which factor solution fits best.
RESULTS: Acceptable fit indices were found in both one-factor confirmatory factor analysis (comparative fit index (CFI) = 0.96; root mean squared error of approximation (RMSEA) = 0.062) and bi-factor analysis (CFI = 0.98; RMSEA = 0.043). Thus, abilities and concerns could be considered as a single dimension. Yet, high loadings on the local factor in bi-factor analysis and slope discrepancies between unidimensional IRT and multidimensional IRT indicate that abilities should be considered as a separate factor from concerns.
CONCLUSIONS: Concerns and abilities could be measured using one-unidimensional item bank. Results also support measuring each construct separately. We recommend a conservative approach by measuring and reporting concerns and abilities separately. We therefore recommend two separate but co-calibrated item banks in the PROMIS network: cognitive function item bank-concerns and cognitive function item bank-abilities. Both item banks showed good psychometric properties and are available for research and clinical purposes.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Cancer; Cognitive Abilities; Cognitive Concerns; Dimensionality; PROMIS; Patient-reported cognitive function

Mesh:

Year:  2014        PMID: 24700645      PMCID: PMC4185008          DOI: 10.1002/pon.3522

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  49 in total

1.  Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.

Authors:  Vincent Koppelmans; Monique M B Breteler; Willem Boogerd; Caroline Seynaeve; Chad Gundy; Sanne B Schagen
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

Review 2.  Subjective cognitive dysfunction in breast cancer patients: a systematic review.

Authors:  Marleen J J Pullens; Jolanda De Vries; Jan A Roukema
Journal:  Psychooncology       Date:  2010-11       Impact factor: 3.894

3.  Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI.

Authors:  A J Saykin; H A Wishart; L A Rabin; R B Santulli; L A Flashman; J D West; T L McHugh; A C Mamourian
Journal:  Neurology       Date:  2006-09-12       Impact factor: 9.910

4.  Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.

Authors:  K Fliessbach; C Helmstaedter; H Urbach; A Althaus; H Pels; M Linnebank; A Juergens; A Glasmacher; I G Schmidt-Wolf; T Klockgether; U Schlegel
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

5.  Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.

Authors:  Kerstin Hermelink; Michael Untch; Michael P Lux; Rolf Kreienberg; Thomas Beck; Ingo Bauerfeind; Karin Münzel
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

6.  Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale.

Authors:  Jin-shei Lai; David Cella; Chih-Hung Chang; Rita K Bode; Allen W Heinemann
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

Review 7.  Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.

Authors:  Heather S L Jim; Kristin M Phillips; Sari Chait; Leigh Anne Faul; Mihaela A Popa; Yun-Hsiang Lee; Mallory G Hussin; Paul B Jacobsen; Brent J Small
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

8.  Evaluating the dimensionality of perceived cognitive function.

Authors:  Jin-Shei Lai; Zeeshan Butt; Lynne Wagner; Jerry J Sweet; Jennifer L Beaumont; Janette Vardy; Paul B Jacobsen; Pamela J Shapiro; Sheri R Jacobs; David Cella
Journal:  J Pain Symptom Manage       Date:  2009-06       Impact factor: 3.612

Review 9.  Cognitive impairment associated with chemotherapy for cancer: report of a workshop.

Authors:  Ian F Tannock; Tim A Ahles; Patricia A Ganz; Frits S Van Dam
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

10.  Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.

Authors:  Nelli Boykoff; Mona Moieni; Saskia Karen Subramanian
Journal:  J Cancer Surviv       Date:  2009-09-16       Impact factor: 4.442

View more
  46 in total

1.  Potential factors associated with perceived cognitive impairment in breast cancer survivors.

Authors:  Jamie S Myers; Jo A Wick; Jennifer Klemp
Journal:  Support Care Cancer       Date:  2015-04-03       Impact factor: 3.603

2.  Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.

Authors:  Haryana M Dhillon; Ian F Tannock; Gregory R Pond; Corrinne Renton; Sean B Rourke; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2017-10-27       Impact factor: 4.442

3.  Pupillary response: cognitive effort for breast cancer survivors.

Authors:  Jamie S Myers; Melike Kahya; Melissa Mitchell; Junqiang Dai; Jianghua He; Sanghee Moon; Kevin Hamilton; Mary Valla; Anne O'Dea; Jennifer Klemp; Monica Kurylo; Abiodun Akinwuntan; Hannes Devos
Journal:  Support Care Cancer       Date:  2018-08-10       Impact factor: 3.603

4.  A dyadic approach for a remote physical activity intervention in adults with Alzheimer's disease and their caregivers: Rationale and design for an 18-month randomized trial.

Authors:  Lauren T Ptomey; Amanda N Szabo-Reed; Eric D Vidoni; Richard A Washburn; Anna M Gorczyca; Todd D Little; Jaehoon Lee; Brian C Helsel; Kristine N Williams; Joseph E Donnelly
Journal:  Contemp Clin Trials       Date:  2020-09-23       Impact factor: 2.226

5.  Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.

Authors:  Lynne I Wagner; Robert J Gray; Joseph A Sparano; Timothy J Whelan; Sofia F Garcia; Betina Yanez; Amye J Tevaarwerk; Ruth C Carlos; Kathy S Albain; John A Olson; Matthew P Goetz; Kathleen I Pritchard; Daniel F Hayes; Charles E Geyer; E Claire Dees; Worta J McCaskill-Stevens; Lori M Minasian; George W Sledge; David Cella
Journal:  J Clin Oncol       Date:  2020-04-09       Impact factor: 44.544

6.  Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study.

Authors:  Sheri J Hartman; Sandahl H Nelson; Emily Myers; Loki Natarajan; Dorothy D Sears; Barton W Palmer; Lauren S Weiner; Barbara A Parker; Ruth E Patterson
Journal:  Cancer       Date:  2017-09-19       Impact factor: 6.860

7.  Relationship between self-reported cognitive function and work-related outcomes in breast cancer survivors.

Authors:  Diane Von Ah; Susan Storey; Adele Crouch
Journal:  J Cancer Surviv       Date:  2017-12-08       Impact factor: 4.442

8.  Establishing clinically-relevant terms and severity thresholds for Patient-Reported Outcomes Measurement Information System® (PROMIS®) measures of physical function, cognitive function, and sleep disturbance in people with cancer using standard setting.

Authors:  Nan E Rothrock; Karon F Cook; Mary O'Connor; David Cella; Ashley Wilder Smith; Susan E Yount
Journal:  Qual Life Res       Date:  2019-08-13       Impact factor: 4.147

9.  Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort.

Authors:  Roxanne E Jensen; Carol M Moinpour; Arnold L Potosky; Tania Lobo; Elizabeth A Hahn; Ron D Hays; David Cella; Ashley Wilder Smith; Xiao-Cheng Wu; Theresa H M Keegan; Lisa E Paddock; Antoinette M Stroup; David T Eton
Journal:  Cancer       Date:  2016-10-03       Impact factor: 6.860

10.  Patient-reported cognitive complaints in older adults with gastrointestinal malignancies at diagnosis- Results from the Cancer & Aging Resilience Evaluation (CARE) study.

Authors:  Nabiel Mir; Paul MacLennan; Mustafa Al-Obaidi; Donna Murdaugh; Kelly M Kenzik; Andrew McDonald; Noha Sharafeldin; Crystal Young-Smith; Ravi Paluri; Olumide Gbolahan; Lakshmin Nandagopal; Smita Bhatia; Grant R Williams
Journal:  J Geriatr Oncol       Date:  2020-03-13       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.